Dual metabolic driver research
Tirzepatide
$75$52.5030% off
The Fat Loss Stack research
A dual GIP and GLP-1 receptor co-agonist peptide studied in clinical research for combined effects on glucose homeostasis, satiety pathways, and body-weight regulation. Premium Research Peptide.
Key benefits
- Dual GLP-1/GIP co-agonism studied for metabolic outcomes
- Investigated for appetite-pathway signaling in research models
- Researched for glucose-dependent insulin secretion endpoints
- Explored for body-composition and metabolic-reset studies
Size: